Chemical Peel Concentration Science: AHA 10–30% Neutralization & Skin Response Protocol

Overview #

pH is not just a stability parameter here. It is the primary ecological lever that determines whether a chemical peel is a cosmetic, a borderline product, or a quasi-drug — depending on which customs officer is reading your label. We formulate AHA systems from 10% all the way to 30% glycolic acid equivalent, and the regulatory gap between those two concentrations is not linear. It is a cliff. What clears EU notification in 48 hours at 10% can trigger a full dossier review at 15%, and in China, anything above certain thresholds enters a registration pathway that takes 6–18 months. Brand partners need to understand this before they brief us on concentration, not after.

The Free Acid Problem: Why Percentage Alone Tells You Nothing #

When a brand owner says “we want 20% glycolic acid,” the first question we ask is: at what pH? Because 20% glycolic at pH 3.8 delivers a completely different free acid fraction than 20% at pH 4.5. The free acid concentration — not the total acid percentage — is what drives both efficacy and regulatory classification in most markets.

In our formulation lab, we calculate free acid percentage using the Henderson-Hasselbalch relationship. Glycolic acid has a pKa of 3.83. At pH 3.5, roughly 67% of the total acid is in the undissociated (active) form. At pH 4.5, that drops to about 18%. Same label claim, completely different product. This is usually where projects go sideways — a brand sees a competitor’s “20% AHA” and assumes they can match it without understanding the pH context.

The EU Cosmetics Regulation 1223/2009 doesn’t regulate AHAs by total percentage alone. The SCCS Scientific Opinion on AHA safety — specifically the 2021 update — sets the combined free acid limit at 6% for rinse-off and 10% for leave-on products at pH no lower than 3.5. That’s the ceiling for cosmetic classification in the EU. Exceed it and you’re in borderline territory. We’ve had clients push back on this, convinced their 15% lactic acid serum was fine because “it’s just lactic acid.” It wasn’t fine. The free acid fraction at their target pH put it over the 10% threshold.

Our internal rule: before we finalize any AHA formula above 10% total concentration, we run the free acid calculation first and present it to the brand alongside the regulatory map. No exceptions.

Market-by-Market Regulatory Limits #

This is where most brands underestimate the complexity. Three major markets, three completely different frameworks, and the differences are not just about numbers — they’re about the type of evidence required, the timeline, and who bears the liability.

European Union

Under EU Cosmetics Regulation 1223/2009, AHA-containing leave-on products must carry a mandatory on-pack warning when the free acid concentration exceeds 3% at pH below 4.5: “Contains AHA. Follow directions carefully. Keep out of reach of children. Avoid contact with eyes.” The Responsible Person must also ensure the Cosmetic Product Safety Report (CPSR) addresses the specific AHA concentration and pH. Notification through the CPNP portal takes 48–72 hours for standard products, but the safety assessment preparation — which we support — typically takes 3–6 weeks depending on the complexity of the formula.

Products positioned as professional-use peels (above 10% free acid) are not cosmetics under EU law. Full stop. We tell every brand this upfront.

United States FDA

The FDA regulates AHA cosmetics under the general cosmetic framework — no pre-market approval, but the FDA Cosmetics Guidelines make clear that products making drug claims (e.g., “treats acne,” “reverses sun damage”) trigger drug classification regardless of concentration. For cosmetic AHA products, the FDA has not set a hard percentage limit, but the agency’s 1992 guidance and subsequent advisory committee recommendations suggest that products above 10% AHA at pH below 3.5 warrant enhanced safety substantiation. In practice, we formulate US-market peels up to 30% glycolic for professional-channel brands, but the labeling, directions for use, and neutralization instructions must be airtight.

One thing we’ve learned: US professional-channel brands often want to push concentration as high as possible. The regulatory pathway is more permissive than EU, but the liability exposure from adverse event reporting (MedWatch) is real. We now require brands to provide a signed formulation brief acknowledging the professional-use positioning before we proceed above 20%.

China NMPA

This is the most complex pathway of the three. Under NMPA Cosmetic Regulation, AHA products are classified as ordinary cosmetics up to certain concentration thresholds, but products with specific efficacy claims — particularly “exfoliation” and “anti-aging” — may require filing as special-use cosmetics. The 2021 Cosmetic Supervision and Administration Regulation (CSAR) and its implementing rules introduced a new efficacy substantiation requirement: brands must provide either clinical or consumer perception data to support on-pack claims. For AHA products, this typically means a human repeat insult patch test (HRIPT) and a dermatologist-assessed tolerability study.

Registration timelines for ordinary cosmetics in China run 3–6 months for domestic manufacturing. For imported products, add another 3–6 months. We’ve seen projects where the brand assumed China registration would mirror their EU timeline. It doesn’t.

Neutralization Protocol: What Actually Happens at the Skin Surface #

Neutralization is the step most brands treat as an afterthought. We don’t. On our production line, we’ve seen what happens when neutralization instructions are vague or absent — and it’s not pretty from a liability standpoint.

A 20% glycolic acid formula at pH 3.2 has a titratable acidity that the skin’s own buffering capacity cannot neutralize quickly. The stratum corneum has a surface pH of approximately 4.5–5.5, but its buffering capacity is limited. At application, the peel drives the skin surface pH down rapidly — in our in-vitro tape-strip models, we’ve measured surface pH dropping to below 3.5 within 90 seconds of application of a 20% glycolic formula. That’s the window where the acid is doing its work: loosening corneodesmosomes, accelerating desquamation, and — if left too long — beginning to compromise the tight junction proteins in the viable epidermis.

Neutralization with a 10–12% sodium bicarbonate solution raises the surface pH back above 6.0 within 30–45 seconds of application. We specify this in every professional peel protocol we develop. The neutralizer volume matters too — we recommend a minimum 2:1 volume ratio of neutralizer to peel product for full surface coverage.

For at-home AHA products (10–15% total, pH 3.5–4.0), self-neutralization via rinsing is the standard approach. We formulate these with a built-in buffering system — typically citrate-phosphate buffer — that limits the depth of pH drop even if the consumer leaves the product on longer than directed. It’s not a perfect solution. But it reduces the adverse event risk meaningfully.

One pilot batch failed because we used a sodium bicarbonate neutralizer that had absorbed atmospheric CO₂ during storage, reducing its effective alkalinity by roughly 15%. We now require suppliers to provide sealed, nitrogen-purged packaging for neutralizer components and test titratable alkalinity on every incoming lot.

Clinical Evidence: What the Peel Actually Does at 20–30% #

The head-to-head data on glycolic acid concentration is actually pretty clear for photoaging endpoints. One double-blind, randomized controlled trial (n=40, 12 weeks, 6 biweekly sessions) comparing 20% vs. 35% glycolic acid peels showed a 34% improvement in Physician Global Assessment score for fine lines in the 35% group versus 21% in the 20% group. What that study doesn’t tell you — and what we’ve learned from our own batches and client feedback — is the tolerability story. The 35% group had a 28% incidence of post-inflammatory hyperpigmentation (PIH) in Fitzpatrick skin types III–IV. That’s a number that should give any brand targeting Asian or Middle Eastern consumers serious pause.

In our formulation work for brands targeting East Asian markets, we almost always recommend staying at 20% total glycolic with pH 3.8–4.0, and pairing it with a niacinamide post-treatment step to manage PIH risk. The efficacy delta between 20% and 30% is real but modest. The PIH risk delta is not modest.

We’re still not fully convinced the clinical evidence for lactic acid at equivalent free acid concentrations matches glycolic. The supplier data and our own stability and efficacy assessments don’t always align. Lactic acid has a higher molecular weight and lower skin penetration rate — which may actually be an advantage for sensitive skin positioning, but the efficacy data at matched free acid concentrations is thinner than the glycolic literature.

For brands wanting to explore our broader acid exfoliation technology platform — including mandelic, malic, and tartaric acid systems — the same free acid calculation principles apply, but the pKa values and penetration kinetics differ enough that we treat each acid as a separate formulation project.

Where Most Brands Get This Wrong #

Honestly, the single most common mistake we see is brands specifying concentration without specifying the delivery format. A 20% glycolic acid peel in a low-viscosity aqueous solution behaves completely differently from 20% glycolic in a gel matrix with 1.5% carbomer. The gel slows spreading, reduces contact uniformity, and — critically — changes the effective contact time because the consumer tends to leave gel formats on longer.

We’ve also seen brands request “30% AHA” without realizing that blended AHA systems (glycolic + lactic + citric) require the free acid calculation to be run on each component separately, then summed. A formula with 15% glycolic, 10% lactic, and 5% citric acid at pH 3.5 has a combined free acid fraction that exceeds the EU cosmetic limit by a significant margin. Three out of five clients who request this kind of blended high-concentration system hit regulatory rejection or stability failure by the time we reach the safety assessment stage.

Scale-up is its own problem. Worked fine at 500g lab scale. At 200kg production, we observed pH drift of 0.3–0.4 units during the mixing phase due to heat generated by the high-shear mixer. At pH 3.5, a 0.3-unit drift changes the free acid fraction enough to push the formula outside its validated range. We now run pH mapping at three points during the production mix cycle and hold a tighter pH specification (±0.1 units) for AHA products above 15% total concentration.

Cost is a real factor here too. Airless pump packaging — which we strongly recommend for AHA peels above 15% to prevent oxidation and contamination — adds $0.50–$0.90 per unit at MOQ 3,000. Most indie brands can’t absorb that at launch. We’ve had to have honest conversations about whether the brand should launch at a lower concentration in standard packaging, or delay launch to build MOQ. Neither answer is wrong. But the conversation needs to happen before tooling is ordered.

Formulation Notes for Brand Partners #

What market? What are you expecting on-pack? Those are the first two questions we ask when a brand comes to us with a peel brief.

If you’re targeting EU and want a leave-on exfoliant, we’re working within the 10% free acid ceiling at pH ≥ 3.5. That’s not a limitation — it’s a design constraint that actually produces better consumer-safe formulas. We can hit meaningful efficacy within that window, especially with optimized vehicle systems and complementary actives like barrier-repair technology to manage post-peel sensitivity.

If you’re targeting the US professional channel, we can go to 20–30% glycolic, but we need your distribution model confirmed before we finalize the formula. Professional-use labeling, neutralization kit inclusion, and training documentation are all part of the package we build.

For China, start the conversation about NMPA filing early — ideally 12 months before your target launch date. We prepare the efficacy substantiation data package, HRIPT reports, and stability dossier as part of our ODM service, but the timeline is not compressible.

The documentation package we prepare for brand partners includes: full CPSR-ready safety assessment data, stability study reports per ICH Stability Guidelines (accelerated 40°C/75% RH, 6 months; real-time 25°C/60% RH, 12 months), HRIPT and dermatologist tolerability reports, free acid calculation worksheets, neutralization protocol documentation, and market-specific labeling review. We’ve built this package iteratively over dozens of peel projects. It’s not glamorous work, but it’s what keeps your product on shelf.

Frequently Asked Questions #

Q: We want to call it “30% AHA” on pack — can we sell that in the EU?

Not as a leave-on cosmetic. The EU free acid limit for leave-on products is 10% at pH ≥ 3.5. A 30% total AHA formula at any reasonable pH will exceed that threshold. You’d need to position it as a professional-use product, which changes your entire distribution and labeling strategy. We can help you model the free acid fraction at different pH targets to find a concentration that works for your market.

Q: How long does China NMPA registration take for an AHA peel?

For a domestically manufactured ordinary cosmetic, budget 3–6 months from submission. If you’re importing, add another 3–6 months. If your formula or claims trigger special-use classification, the timeline extends further. We’ve seen total timelines of 12–18 months for complex AHA products with multiple efficacy claims. Start early.

Q: What’s the minimum pH we can go to for a retail product?

For EU, pH 3.5 is the regulatory floor for leave-on AHA cosmetics. For US retail, there’s no hard regulatory limit, but we won’t formulate below pH 3.2 for any retail-channel product — the adverse event risk is too high and the liability exposure isn’t worth it. Most of our retail AHA formulas sit at pH 3.5–4.0.

Q: Do we need a neutralizer kit included with a professional peel?

For anything above 20% total AHA, yes — we strongly recommend it and will flag the absence as a risk in our formulation brief. A 10–12% sodium bicarbonate neutralizer raises surface pH above 6.0 within 30–45 seconds. Without it, you’re relying on the practitioner to have their own neutralizer on hand, which introduces inconsistency. The kit adds cost — roughly $0.30–$0.60 per unit for a single-use sachet — but it’s the right call.

Q: Can we combine AHAs with retinol in the same peel formula?

We almost always push back on this brief. At the pH required for AHA activity (3.5–4.0), retinol stability drops sharply — we see significant retinol degradation within 4 weeks at 40°C in combined formulas. The two actives are better positioned as a two-step protocol: AHA peel first, retinol treatment after the skin barrier has recovered. If you want both on-pack, we can design a dual-phase or sequential-use system, but it adds formulation complexity and cost.

Have a product concept in mind? Contact our formulation team to request a complimentary brief review.